DHX33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.763400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.504400E-01
Normal-vs-Stage2
5.910000E-01
Normal-vs-Stage3
6.502500E-02
Normal-vs-Stage4
8.081000E-01
Stage1-vs-Stage2
5.127200E-01
Stage1-vs-Stage3
3.511700E-02
Stage1-vs-Stage4
7.089200E-01
Stage2-vs-Stage3
6.500300E-02
Stage2-vs-Stage4
3.411200E-01
Stage3-vs-Stage4
1.555680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.644000E-01
Normal-vs-AfricanAmerican
9.479200E-01
Normal-vs-Asian
3.301000E-01
Caucasian-vs-AfricanAmerican
4.942800E-01
Caucasian-vs-Asian
2.273800E-01
AfricanAmerican-vs-Asian
2.484800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.948000E-01
Normal-vs-Female
6.875200E-01
Male-vs-Female
3.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.156000E-01
Normal-vs-Age(41-60Yrs)
9.147200E-01
Normal-vs-Age(61-80Yrs)
4.301600E-01
Normal-vs-Age(81-100Yrs)
5.379400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.314400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.739400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.477000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.083500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.122000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.666800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.432200E-01
Normal-vs-Daily Drinker
1.454350E-01
Normal-vs-Weekly Drinker
9.450800E-01
Normal-vs-Occasional Drinker
7.187600E-01
Normal-vs-Social Drinker
9.805600E-01
Non Drinker-vs-Daily Drinker
1.162960E-01
Non Drinker-vs-Weekly Drinker
2.901600E-01
Non Drinker-vs-Occasional Drinker
4.815200E-01
Non Drinker-vs-Social Drinker
1.591550E-01
Daily Drinker-vs-Weekly Drinker
4.415600E-02
Daily Drinker-vs-Occasional Drinker
4.980100E-02
Daily Drinker-vs-Social Drinker
1.422370E-02
Weekly Drinker-vs-Occasional Drinker
6.840400E-01
Weekly Drinker-vs-Social Drinker
8.702600E-01
Occasional Drinker-vs-Social Drinker
5.099600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.436200E-01
Normal-vs-Grade 2
9.867000E-01
Normal-vs-Grade 3
9.094000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.016400E-01
Grade 1-vs-Grade 3
4.169600E-01
Grade 1-vs-Grade 4
9.436200E-01
Grade 2-vs-Grade 3
1.856980E-01
Grade 2-vs-Grade 4
9.867000E-01
Grade 3-vs-Grade 4
9.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.850600E-01
Normal-vs-NonDiabetic
4.791600E-01
Diabetic-vs-NonDiabetic
8.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.307800E-01
Normal-vs-NoPancreatitis
5.061200E-01
Pancreatitis-vs-NoPancreatitis
6.596400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.557200E-01
Normal-vs-N1
6.056000E-01
N0-vs-N1
6.563800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.238000E-01
Normal-vs-TP53-NonMutant
8.662800E-01
TP53-Mutant-vs-TP53-NonMutant
7.159600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
